| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.8832 | 36 |
| GSM780708 | Untreated after 4 days (C2_1) | 38.7712 | 4 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.0963 | 37 |
| GSM780719 | Untreated after 4 days (C1_2) | 41.5637 | 11 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.1651 | 28 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.297 | 38 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 41.2276 | 10 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 37.4682 | 2 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.5498 | 5 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.7372 | 48 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 39.7966 | 6 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.2051 | 52 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.2266 | 23 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 51.436 | 53 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.3148 | 46 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.1584 | 14 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.9527 | 41 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.5645 | 53 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.3592 | 29 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.4348 | 29 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.0288 | 6 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 55.9293 | 61 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 42.1024 | 14 |